Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer

Colorectal Disease

Volumn 15, Issue 5, 2013, Pages 552-557

  Arredondo, J ^a   Pastor, C ^b   Baixauli, J ^a   Rodriguez J ^a   Gonzalez I ^a   Vigil, C ^a   Chopitea, A ^a   Hernandez Lizoain J L ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Locally advanced colon cancer; Neoadjuvant treatment; Stage III colon cancer

Indexed keywords

CAPECITABINE PLUS OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASTHENIA; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; COLON CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIARRHEA; DRUG INTOXICATION; FEMALE; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; MALE; NAUSEA; NEUROTOXICITY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PRIORITY JOURNAL; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OPERATIVE TIME; ORGANOPLATINUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877003583     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12119     Document Type: Article

References (26)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds (2010). AJCC Cancer Staging Manual, 7th edn. pp 143-64. Springer, New York, NY.
3. Nelson H, Petrelli N, Carlin A etal. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93: 583-96.
4. Lombardi L, Morelli F, Cinieri S etal. Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev 2010; 36(3): S34-41.
5. NCCN Clinical Practice Guidelines in Oncology. http://www.nccn.org/ (accessed 17 November 2011).
6. Sauer R, Becker H, Hohenberger W etal. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-40.
7. Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol 2008; 14: 3773-80.
8. Habr-Gama A, Perez R, Proscurshim I, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am 2010; 19: 829-45.
9. Maas M, Nelemans PJ, Valentini V etal. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-44.
10. FOxTROT Trial. University of Birmingham. UK. http.//www.foxtrot.bham.ac.uk/ (accessed 17 November 2011).
11. Annual Foxtrot. Annual Collaborators' Meeting- FOxTROT Trial. http.//www.nwlcn.nhs.uk/ (accessed 17 November 2011).
12. A Pilot Study of Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer. (NCT00826800). Memorial Sloan-Kettering Cancer Center. http://www.clinicaltrials.gov/ (accessed 17 November 2011).
13. Andre T, Boni C, Navarro M etal. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109-16.
14. Van Cutsem E, Labianca R, Bodoky G etal. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol 2009; 27: 117-3125.
15. Ychou M, Raoul JL, Douillard JY etal. A phase III randomised trial of LV5FU2+ irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). Ann Oncol 2009; 20: 674-80.
16. Alberts SR, Sargent DJ, Nair S etal. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA 2012; 307: 1383-93.
17. Allegra CJ, Yothers G, O'Connell MJ etal. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol 2011; 29: 11-6.
18. Trarbach T, Kubicka S, Hacker U, Ridwelski K, Reinacher-Schick A. Adjuvant therapy of colon carcinoma. Onkologie 2008; 31(Suppl 5): 19-23.
19. Hendren S, Birkmeyer JD, Yin H, Banerjee M, Sonnenday C, Morris AM. Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer. Dis Colon Rectum 2010; 53(12): 1587-93.
20. Benson AB III, Schrag D, Somerfield MR etal. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22: 3408-19.
21. Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 2004; 22: 3395-407.
22. Bayraktar UD, Chen E, Bayraktar S etal. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? Cancer 2011; 117: 2364-70. doi:10.1002/cncr.25720.
23. Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 2011; 305(22): 2335-42.
24. Dighe S, Swift I, Magill L etal. Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience. Colorectal Dis 2012; 14: 438-44.
25. Huh JW, Jeong YY, Kim HR, Kim YJ. Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer. Ann Oncol 2012; 23: 1198-206.
26. Cascini GL, Avallone A, Delrio P etal. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006; 47: 1241-8.